Pre-treatment of STZ-induced, diabetic, Sprague–Dawley rats with nanosystems encapsulating curcumin (nCurcumin; 50 mg/kg b.w./day) for 28 days resulted in reduced serum glucose levels and increased insulin levels, indicating reduced hyperglycemia [49]. The gene discussed is INS; the disease is Hyperglycemia.